Sensitization of epithelial growth factor receptors by nicotine exposure to promote breast cancer cell growth
Open Access
- 15 November 2011
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 13 (6) , R113
Abstract
Introduction: Tobacco smoke is known to be the main cause of lung, head and neck tumors. Recently, evidence for an increasing breast cancer risk associated with tobacco smoke exposure has been emerging. We and other groups have shown that nicotine, as a non-conventional carcinogen, has the potential to facilitate cancer genesis and progression. However, the underlying mechanisms by which the smoke affects the breast, rather than the lung, remain unclear. Here, we examine possible downstream signaling pathways of the nicotinic acetylcholine receptor (nAChR) and their role in breast cancer promotion. Methods: Using human benign MCF10A and malignant MDA-MB-231 breast cells and specific inhibitors of possible downstream kinases, we identified nAChR effectors that were activated by treatment with nicotine. We further tested the effects of these effector pathways on the regulation of E2F1 activation, cell cycle progression and on Bcl-2 expression and long-term cell survival. Results: In this study, we demonstrated a novel signaling mechanism by which nicotine exposure activated Src to sensitize epidermal growth factor receptor (EGFR)-mediated pathways for breast cancer cell growth promotion. After the ligation of nAChR with nicotine, EGFR was shown to be activated and then internalized in both MCF10A and MDA-MB-231 breast cancer cells. Subsequently, Src, Akt and ERK1/2 were phosphorylated at different time points following nicotine treatment. We further demonstrated that through Src, the ligation of nicotine with nAChR stimulated the EGFR/ERK1/2 pathway for the activation of E2F1 and further cell progression. Our data also showed that Akt functioned directly downstream of Src and was responsible for the increase of Bcl-2 expression and long-term cell survival. Conclusions: Our study reveals the existence of a potential, regulatory network governed by the interaction of nicotine and nAChR that integrates the conventional, mitogenic Src and EGFR signals for breast cancer development.Keywords
This publication has 39 references indexed in Scilit:
- E2F1 Regulates Cellular Growth by mTORC1 SignalingPLOS ONE, 2011
- Cigarette Smoking and the Incidence of Breast CancerArchives of internal medicine (1960), 2011
- Nicotine, through upregulating pro‐survival signaling, cooperates with NNK to promote transformationJournal of Cellular Biochemistry, 2009
- C/EBPβ-mediated transcriptional regulation of bcl-xl gene expression in human breast epithelial cells in response to cigarette smoke condensateOncogene, 2008
- Nicotine Promotes Mammary Tumor Migration via a Signaling Cascade Involving Protein Kinase C and cdc42Cancer Research, 2008
- Nicotine induces cell proliferation, invasion and epithelial‐mesenchymal transition in a variety of human cancer cell linesInternational Journal of Cancer, 2008
- Nicotine induces cell proliferation by -arrestin-mediated activation of Src and Rb-Raf-1 pathwaysJournal of Clinical Investigation, 2006
- Persistent Nicotine Treatment Potentiates Amplification of the Dihydrofolate Reductase Gene in Rat Lung Epithelial Cells as a Consequence of Ras ActivationJournal of Biological Chemistry, 2005
- Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathwayCancer Cell, 2005
- EGFR and cancer prognosisEuropean Journal of Cancer, 2001